LATS2 and neoplasm: A LATS2 in-frame deletion insertion missense variant, SL425PP, was detected in the SB tumor from F8 that did not harbor NF2 or chromosome 22 alterations (Figure 2A,B, Tables S2 and S3), raising the possibility of independent mutations in the NF2-Hippo pathway in this ED group.